This article will also serve to discuss the mechanisms by which aberrations of the SMARCB1 gene occur and their implications in driving the various hallmarks of cancer and provide an overview of the novel therapeutic approaches in clinical trials for treatment of RTs. The gene discussed is SMARCB1; the disease is cancer.